Showing 1,141 - 1,160 results of 9,864 for search '"drug"', query time: 0.08s Refine Results
  1. 1141

    Adaptation of the five-factor BFI-10 personality screening questionnaire and testing of its diagnostic properties on the example of drug users by О. О. Serdiuk, В. О. Bazyma

    Published 2021-12-01
    “…The BFI-10 adapted variant has showed its diagnostic applicability in a study of drug and non-drug users (N = 4723). The results of the comparison of the average values of the BFI-10 scales (t-test) show that there are statistically significant differences between young people who used and did not use drugs in the 12 months before the survey. …”
    Get full text
    Article
  2. 1142
  3. 1143
  4. 1144
  5. 1145

    Forecasting the effect of water gastric emptying patterns on model drug release in an in vitro glass-bead flow-through system by Felicijan Tjaša, Bogataj Marija

    Published 2024-06-01
    “…Further, the effect of GE on the dissolution of model drugs from immediate-release tablets was assessed by determining the amount of dissolved drug in the samples pumped out of the stomach compartment. …”
    Get full text
    Article
  6. 1146
  7. 1147

    AI-driven prediction of drug activity against Toxoplasma gondii: Data augmentation and deep neural networks for limited datasets by Natalia V. Karimova, Ravithree D. Senanayake

    Published 2025-06-01
    “…Finally, the model was applied to screen FDA-approved drugs after filtering out molecules that did not align with the characteristics of the training dataset. …”
    Get full text
    Article
  8. 1148

    Comparison of Liver Biopsy Findings with the Digestive Disease Week Japan 2004 Scale for Diagnosis of Drug-Induced Liver Injury by Akemi Tsutsui, Yasuni Nakanuma, Kouichi Takaguchi, Satoko Nakamura, Hiroshi Shibata, Nobuyuki Baba, Tomonori Senoh, Takuya Nagano, Hiroko Ikeda

    Published 2015-01-01
    “…The liver biopsy remains a valuable tool in the diagnosis of drug-induced liver injury (DILI). The Digestive Disease Week Japan 2004 (DDW-J) scale proposed as an objective tool for the diagnosis of DILI has been widely used in Japan. …”
    Get full text
    Article
  9. 1149
  10. 1150

    Antimicrobial Activity of <i>Zingiber Officinale</i> and <i>Allium Sativum</i> on some Drug Resistant Bacterial Isolates by S.E. Emmanuel, E.O. Ehinmitan, R.S. Bodunde, J.C. Joseph

    Published 2021-11-01
    “… Ginger and garlic are very important and useful spices and are used as therapeutic agent against many pathological infections. Increasing multi-drug resistance of pathogens forces researchers to find alternative compounds for treatment of infectious diseases. …”
    Get full text
    Article
  11. 1151
  12. 1152

    Lipid-based systems with precipitation inhibitors as formulation approach to improve the drug bioavailability and/or lower its dose: a review by Kovačević Mila, Gašperlin Mirjana, Pobirk Alenka Zvonar

    Published 2024-06-01
    “…Lipid-based systems, such as self-microemulsifying systems (SMEDDS) are attracting strong attention as a formulation approach to improve the bioavailability of poorly water-soluble drugs. By applying the “spring and parachute” strategy in designing supersaturable SMEDDS, it is possible to maintain the drug in the supersaturated state long enough to allow absorption of the complete dose, thus improving the drug’s bio-availability. …”
    Get full text
    Article
  13. 1153

    Direct and Indirect Drug Design Approaches for the Development of Novel Tricyclic Antipsychotics: Potential 5-HT2A Antagonist by Mahantesh Namdev Jadhav, Ganesh Rajendra Kokil, Shilpa Sudhakar Harak, Sanjay Baburao Wagh

    Published 2013-01-01
    “…Given the therapeutic and toxic limitations of clinically available drugs, it is clear that there is still a need for the development of new generation antipsychotic agents with an improved clinical profile. …”
    Get full text
    Article
  14. 1154
  15. 1155

    Analysis of Protein-Ligand Interactions of SARS-CoV-2 Against Selective Drug Using Deep Neural Networks by Natarajan Yuvaraj, Kannan Srihari, Selvaraj Chandragandhi, Rajan Arshath Raja, Gaurav Dhiman, Amandeep Kaur

    Published 2021-06-01
    “…The DNN senses the response of protein-ligand interactions for a specific drug and identifies which drug makes the interaction that combats effectively the virus. …”
    Get full text
    Article
  16. 1156

    Possibility of using a mouse SCID as a model animal to variola virus for evaluating anti-smallpox drug efficacy by K. A. Titova, Al. A. Sergeev, A. S. Kabanov, L. E. Bulychev, Ar. A. Sergeev, D. O. Galahova, A. S. Zamedyanskaya, L. N. Shishkina, O. S. Taranov, V. V. Omigov, E. L. Zavjalov, A. P. Agafonov, A. N. Sergeev

    Published 2015-12-01
    “…This opens up the prospect of using SCID mice as an animal model for smallpox to develop antiviral drugs intended for people with severe immuno­suppressive states.…”
    Get full text
    Article
  17. 1157

    A Real-World, Multicenter Assessment of Drugs Requiring Weight-Based Calculations in Overweight, Adult Critically Ill Patients by Sandra L. Kane-Gill, Nicholas P. Wytiaz, Lisa M. Thompson, Karina Muzykovsky, Mitchell S. Buckley, Henry Cohen, Amy L. Seybert

    Published 2013-01-01
    “…Prescribing appropriate doses of drugs requiring weight-based dosing is challenging in overweight patients due to a lack of data. …”
    Get full text
    Article
  18. 1158

    The antidepressant drug sertraline is a novel inhibitor of yeast Pah1 and human lipin 1 phosphatidic acid phosphatases by Geordan J. Stukey, Matthew R. Breuer, Natalie Burchat, Ruta Jog, Kollin Schultz, Gil-Soo Han, Matthew S. Sachs, Harini Sampath, Ronen Marmorstein, George M. Carman

    Published 2025-01-01
    “…The Pah1-CC (catalytic core) variant, which lacks regulatory sequences, was inhibited by both drugs in accordance with molecular docking data. …”
    Get full text
    Article
  19. 1159

    Use of failure mode and effect analysis to improve the monoclonal antibody drugs management process in pharmacy intravenous admixture services by Jian Cai, Min-Xian Li, Shuai Lu, Dan Shen, Wei Xie, Jian-Jun Zhu, Guo-Jun Jiang, Chun-Xiao Lu

    Published 2025-02-01
    “…Through refinement, we successfully mitigated the occurrence of high-risk failure modes of mAb drugs in PIVAS. These efforts are aimed at enhancing the safety and efficacy of mAb drugs, ultimately ensuring patient safety.…”
    Get full text
    Article
  20. 1160

    South African Rheumatism and Arthritis Association 2024 guidelines for the use of biologic and targeted synthetic disease-modifying antirheumatic drugs by E van Duuren, J Potts, U Brijlal, S Botha, S Didi, K Makan, M van Dam, K Chinniah, B Hodkinson

    Published 2024-09-01
    “… Biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) target a specific pathway of the immune system, and are usually prescribed after failure of conventional synthetic disease-modifying antirheumatic drug therapy. …”
    Get full text
    Article